US2013052245A1PendingUtilityA1

Cosmetic and dermatological formulations of mntf peptides

Assignee: DERMACARE NEUROSCIENCE INSTPriority: Feb 21, 2008Filed: Oct 24, 2012Published: Feb 28, 2013
Est. expiryFeb 21, 2028(~1.6 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 39/06A61P 29/00A61P 17/02A61P 17/00A61P 17/18A61K 8/361A61Q 19/02A61K 8/64C07K 14/475A61K 38/185A61Q 17/04A61Q 19/08
43
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The disclosure is directed to methods and compositions that include MNTF peptides and their analogs for cosmetic and dermatological purposes.

Claims

exact text as granted — not AI-modified
1 . A topical skin rejuvenating or protecting composition comprising:
 a) an effective amount of a MNTF peptide having an amino acid sequence comprising at least three consecutive amino acids of SEQ ID NO:1; and   b) a cosmetically, dermatologically or pharmaceutically acceptable carrier.   wherein said a MNTF peptide does not have an amino acid sequence according to SEQ ID NO:2.   
     
     
         2 . The composition according to  claim 1  wherein said MNTF peptide or analog thereof has between 3 and 5 consecutive amino acids of SEQ ID NO:1. 
     
     
         3 . The composition according to  claim 1  wherein said MNTF peptide or analog thereof is selected from the group consisting of SEQ ID NOS:4-27. 
     
     
         4 . The composition according to  claim 1  wherein said MNTF peptide or analog thereof have at least three consecutive amino acids according to SEQ ID NO:9. 
     
     
         5 . The composition according to  claim 1  wherein said MNTF peptide or analog thereof comprises SEQ ID NO:17. 
     
     
         6 . The composition according to  claim 1  wherein said MNTF peptide or analog thereof consists of SEQ ID NO:17. 
     
     
         7 . The composition according to  claim 1 , wherein said MNTF peptide is modified by covalent linkage with a penetration enhancer, whereby the tissue penetration ability of the composition is improved. 
     
     
         8 . The composition according to  claim 7 , wherein said MNTF peptide is N-terminally modified by covalent linkage to said penetration enhancer. 
     
     
         9 . The composition according to  claim 8 , wherein said penetration enhancer is covalently attached to said MNTF peptide by N-acyl derivatives of free amino groups. 
     
     
         10 . The composition-according to  claim 9 , wherein said penetration enhancer is an optionally substituted alkyl carboxylic acid of 2 to 22 carbons, wherein said alkyl carboxylic acid is optionally hydroxylated, unsaturated, and/or sulfurated. 
     
     
         11 . The composition according to  claim 10 , wherein said penetration enhancer is a fatty acid is selected from cabrylic acid, oleic acid, lauric acid, capric acid, caprylic acid, hexanoic acid, myristic acid, palmitic acid, valeric acid, stearic acid, linoleic acid, linolenic acid, arachidonic acid, oleic acid, elaidic acid, erucic acid, nervonic acid. 
     
     
         12 . The composition according to  claim 1 , wherein:
 (a) the amount of peptide is encapsulated in a vector selected from the group consisting of macro-capsules, micro-capsules, nano-capsules, liposomes, chylomicrons and microsponges, or   (b) said peptide is absorbed on a material selected from the group consisting of powdered organic polymers, tales, bentonites, and other mineral supports, or   (c) said peptide is mixed with other ingredients selected from a group comprising extracted lipids, vegetable extracts, liposoluble active principles, hydrosoluble active principles, anhydrous gels, emulsifying polymers, tensioactive polymers, synthetic lipids, gelifying polymers, tissue extracts, marine extracts, Vitamin A, Vitamin C, Vitamin D, Vitamin E, solar filters, and antioxidants.   
     
     
         13 . A method for rejuvenating or protecting skin, the method comprising topically administering a composition according to  claim 1  to a subject, wherein the composition is administered in an amount effective to promote the rejuvenation or protection of skin. 
     
     
         14 . The method according to  claim 13 , wherein the method reduces or inhibits photodamage associated inflammation or free radical damage in a subject in need thereof. 
     
     
         15 . The method according to  claim 13 , wherein the method reduces peroxides or free radical generation in the skin in a subject in need thereof. 
     
     
         16 . The method according to  claim 13 , wherein the method reduces wrinkles in a subject in need thereof. 
     
     
         17 . The method according to  claim 13 , wherein the method improves skin tone in a subject in need thereof. 
     
     
         18 . The method according to  claim 13 , wherein the method reduces UV or photodamage in the skin in a subject in need thereof. 
     
     
         19 . The method according to  claim 13 , wherein the method promotes skin regeneration in a subject in need thereof. 
     
     
         20 . A method for improving an acne scar in a subject suffering therefrom, the method comprising topically administering a composition according to  claim 1  to a subject, wherein the composition is administered in an amount effective to improve said acne scar. 
     
     
         21 . A method for reducing keloid formation in a subject in need thereof, the method comprising topically administering a composition according to  claim 1  to a subject, wherein the composition is administered in an amount effective to reduce said keloid formation.

Join the waitlist — get patent alerts

Track US2013052245A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.